Case Study 36.1: Anti-Smoking Campaigns — Truthful Emotional Persuasion

"The Real Cost" and the Decades-Long Experiment in Ethical Fear Appeals

Introduction

Between 1964 and 2020, adult smoking rates in the United States declined from approximately 42% to 12.5% — one of the largest sustained behavior changes in modern public health history. The decline was not linear, and no single campaign produced it. It resulted from a combination of federal regulation, litigation, tax policy, workplace smoking restrictions, and, running throughout, decades of communication campaigns that had to figure out a hard practical problem: how do you persuade people to stop doing something that is immediately pleasurable, socially reinforced, and physiologically addictive, using only accurate information?

The history of anti-tobacco communication is, in part, a history of ethical mistakes and what was learned from them — and eventually, what ethical fear appeals can achieve when designed correctly.

This case study examines two distinct phases of this history: (1) the communication strategies that failed, and why they failed in ways that illuminate ethical as well as practical problems; and (2) the FDA's "The Real Cost" campaign (2014–present), which has become a landmark example of ethical emotional persuasion in public health communication.

Phase One: What Didn't Work, and Why

The Early PSA Era (1967–1980)

The Federal Communications Commission's fairness doctrine, applied to cigarette advertising in 1967, required broadcast media to provide free airtime for anti-smoking public service announcements. For three years, until cigarette advertising was banned from broadcast media entirely in 1971, anti-smoking PSAs aired alongside tobacco advertising in roughly equal time. Researchers later analyzed this period and found that the PSAs were associated with a decline in cigarette consumption — one of the few naturally occurring quasi-experiments in which anti-tobacco communication could be measured against a control (Hamilton, 1972).

But the PSAs of this era had a significant ethical problem alongside their effectiveness. Many relied on shock imagery and exaggerated mortality claims — statistics presented without the nuance that would allow audiences to assess their actual personal risk. Some used fear in ways that the EPPM framework would later identify as counterproductive: high threat, low efficacy. Audiences were shown horrifying images of lung disease without being given realistic information about cessation options, without efficacy-building content, and without the kind of specific, actionable guidance that enables protective rather than defensive responses.

The era established anti-tobacco communication as a field — but it also established some practices that would prove counterproductive as they were inherited by later campaigns.

The "Truth" Campaign and Its Lessons (1998–present)

The American Legacy Foundation's "truth" campaign, launched following the 1998 Master Settlement Agreement with tobacco companies, is a significant and instructive case in communication ethics. The campaign explicitly targeted adolescents with the goal of preventing smoking initiation, and it developed a distinctive strategy: rather than warning teenagers about health risks — a message the research suggested teenagers were largely able to ignore through optimistic bias about their own mortality — it reframed smoking as a corporate manipulation of young people.

The "truth" campaign told teenagers: the tobacco industry manipulates you to make money off your addiction. It positioned anti-smoking not as the health-cautious choice but as the rebellious, independent choice. This was a sophisticated application of adolescent psychology — teenagers who discount health warnings will respond to messages about autonomy and authenticity — and the research found that exposure to "truth" advertising was associated with reduced smoking intentions and initiation (Farrelly et al., 2002).

The ethical dimension of this strategy is genuinely complex. The campaign's core factual claim — that the tobacco industry manipulates young people to create addicted customers — is well-supported by documentary evidence, much of it produced through tobacco industry litigation. The emotional frame — anger at manipulation rather than fear of disease — is accurate in its representation of the industry's practices. The campaign did not exaggerate or fabricate; it selected an accurate angle of approach calibrated to the specific audience.

But the "truth" campaign also illustrates the tension between accuracy and proportionality that runs through all emotional framing. The campaign's emotional intensity — its visceral, confrontational style — was calibrated to generate the kind of strong emotional response that would drive behavioral change. Is strong emotional intensity, even when the underlying facts are accurate, itself an ethical concern? The autonomy respect criterion would suggest that the question depends on whether the emotional response enhances or suppresses rational evaluation. A teenager who watches a "truth" advertisement and thinks "I'm being manipulated by tobacco companies, I should look into this" has had their rational evaluation enhanced. A teenager who watches the same advertisement and feels such revulsion at the tobacco industry that they cannot think clearly about the underlying evidence has had it suppressed. The line between these outcomes is not always visible in the communication itself.

Phase Two: "The Real Cost" — An Ethical Model

Design and Context

The FDA launched "The Real Cost" in February 2014 as its first direct-to-consumer anti-tobacco campaign. The campaign had a specific target: at-risk youth aged 12 to 17 who had already used tobacco and were at risk of escalating use. FDA research had identified this population — experimenting or occasional users who had not yet become daily smokers — as the group where prevention resources could have the highest impact.

The campaign's design was shaped by extensive pre-production research, including focus groups, message testing, and expert review of the adolescent psychology and risk communication literature. The design team made several choices that are instructive from an ethical standpoint.

Choice 1: Match the threat to the audience's actual risk horizon. Research on temporal discounting consistently finds that adolescents (and, to a lesser degree, adults) discount long-term consequences steeply. A fear appeal about lung cancer — a disease that will potentially appear in forty or fifty years — has minimal behavioral impact on a seventeen-year-old. "The Real Cost" instead focused on immediate and near-term consequences: tooth decay and tooth loss from smokeless tobacco; skin damage from cigarette smoking; reduced athletic performance; and the financial cost of a tobacco habit ("What are you trading for your tobacco?"). These were not fabricated consequences — they are documented effects of tobacco use, many of which begin appearing within years or even months of regular use. The campaign was selecting accurate information calibrated to its audience's actual cognitive processing, not distorting evidence to maximize impact.

Choice 2: Provide an efficacy response. Every "The Real Cost" advertisement paired the fear content with a specific action the audience could take. The campaign drove traffic to smokefree.gov, where cessation resources were available, and to a text-based cessation support program. The EPPM criterion — that ethical fear appeals must pair high threat with high efficacy — was met explicitly. Audiences were not left with fear and no pathway.

Choice 3: Be transparent about source and intent. Every piece of "The Real Cost" content is clearly identified as coming from the FDA. The FDA's regulatory authority and mission are publicly known. There is no concealment of source or of the campaign's persuasive intent.

Choice 4: Keep the factual claims accurate and proportionate. The FDA's own research team verified that every factual claim in the campaign met accuracy standards. The campaign did not claim, for example, that every teenager who tries a cigarette will become addicted, or that tooth loss from tobacco use was certain or immediate — only that these were real consequences that could occur.

The "Skin" Campaign

One of the most memorable executions was the "Skin" campaign, which depicted a teenager peeling away a patch of skin from his face and handing it to a tobacco store cashier in exchange for cigarettes — visualizing the tagline "What are you trading for your tobacco?"

The visual imagery is viscerally disturbing — deliberately so. But it meets the ethical criteria for fear appeals: the threat is real (tobacco causes skin damage and premature aging, documented in the research), the fear is calibrated to an actual risk rather than an exaggerated one, and the advertisement includes information about the specific tradeoff and the available alternative. The imagery makes accurate information emotionally vivid without manufacturing a false impression of the underlying evidence.

Some critics argued that the imagery was disproportionately disturbing relative to the actual immediate risk of skin damage from smoking — that the campaign was using shock value to bypass rational evaluation. This is a legitimate ethical concern that the campaign designers had to navigate. Their response, documented in the campaign's research reports, was that the imagery was effective precisely because it made a real risk vivid to an audience that was otherwise inclined to discount it, and that the underlying risk was accurately represented rather than fabricated.

Outcomes and Evaluation

The FDA commissioned an independent evaluation of "The Real Cost" campaign using a quasi-experimental design — comparing youth tobacco use trends in markets with higher campaign exposure to markets with lower exposure, controlling for other factors that influence youth smoking rates.

The Farrelly et al. (2017) evaluation found that exposure to "The Real Cost" advertising was associated with a statistically significant reduction in youth tobacco use initiation. The study estimated that approximately 587,000 youth who would otherwise have become regular tobacco users did not, during the 2014–2016 period that the study evaluated. The finding was robust across multiple analytical approaches and controls.

This is not a claim that the campaign alone produced this outcome — anti-tobacco policy, tax increases, and other communication campaigns were operating simultaneously. It is a claim, supported by the research design, that exposure to "The Real Cost" advertising was independently associated with the measured reduction in initiation.

The outcome matters for the ethical persuasion question: this is a case where a communication campaign met all five ethical criteria from 36.1, met the four conditions for ethical fear appeals from 36.2, and was associated with significant measured behavioral change. It is not proof that ethical campaigns always win. It is evidence that they can, under the right conditions.

The Ethical Contrast: D.A.R.E. and the Counterproductive Campaign

Understanding "The Real Cost" as ethical requires understanding its contrast: campaigns that violated the ethical criteria and, relatedly, did not achieve their behavioral goals.

The Drug Abuse Resistance Education (D.A.R.E.) program, launched in 1983 and operating in roughly 75% of American school districts at its peak, was one of the largest and most expensive anti-drug communication programs in American history. Its method: uniformed police officers delivering drug resistance education to elementary school children, emphasizing the dangers of drug use and providing refusal skills.

Multiple independent evaluations found that D.A.R.E. participation was not associated with reduced drug use relative to control groups. Some studies found no difference; others found marginally higher drug use rates among D.A.R.E. participants in later adolescence, possibly due to reactance effects — the program's emphasis on resisting peer pressure may have ironically increased the salience of peer pressure as a relevant factor in drug decisions.

The D.A.R.E. failure is partly an effectiveness failure and partly an ethics failure. The program:

• Exaggerated the risks of marijuana in ways that were not proportionate to the actual evidence, leading adolescents who encountered marijuana and found the experience less catastrophic than advertised to discount the program's credibility entirely
• Provided limited efficacy content — it emphasized danger without providing realistic coping strategies for situations that adolescents would actually encounter
• Used fear in ways that EPPM research would predict produce defensive rather than protective responses for at-risk youth
• Did not disaggregate different drugs or different risk profiles, treating all drug use as equivalently catastrophic in ways that were both inaccurate and counterproductive

The D.A.R.E. case illustrates that the accuracy and proportionality criteria are not merely ethical requirements — they are also effectiveness requirements. Fear appeals that exaggerate risks for rhetorical effect backfire when audiences discover the exaggeration, and they do discover it.

What This Case Teaches About Ethical Persuasion

Finding 1: Ethical constraints and effective design can be aligned. "The Real Cost" demonstrates that the five ethical criteria are not merely restrictions on what communicators are allowed to do; they are also, in this case, specifications that contributed to effectiveness. Accurate, proportionate, efficacy-paired messaging that respects the audience's actual cognitive processing is also better-designed messaging.

Finding 2: Emotional intensity is not the same as ethical violation. The "Skin" campaign is emotionally disturbing. This does not make it unethical. The ethical question is whether the emotional intensity is proportionate to actual risk and designed to mobilize rather than paralyze rational evaluation. "The Real Cost" meets these criteria; D.A.R.E.'s exaggeration-based messaging did not.

Finding 3: Audience knowledge matters for ethical design. "The Real Cost"'s most important ethical choice was to match its messaging to what the research showed its audience actually knew, believed, and processed — not to what the designers assumed or hoped. The decision to focus on immediate rather than long-term consequences was an evidence-based decision about what would be relevant to the target audience, not an abandonment of accuracy. This kind of audience research is not just practical — it is an ethical requirement for communicators who claim to respect audience autonomy.

Finding 4: Long-term accountability distinguishes ethical from unethical emotional persuasion. "The Real Cost" is a government campaign that is evaluated, published, and subject to public scrutiny. When the FDA makes a factual claim in the campaign, it is accountable for that claim in ways that a private organization or political campaign is not. The institutional accountability structure is part of what makes the campaign ethically sound — not just the content of the messages.

Discussion Questions

1. The "truth" campaign and "The Real Cost" both use emotional appeals but with different strategies: "truth" uses anger at corporate manipulation; "The Real Cost" uses immediate health fears. Apply the autonomy respect criterion to both. Does either campaign risk bypassing rational evaluation? How would you assess the ethical difference between the two approaches?

2. Critics of "The Real Cost" have argued that government public health campaigns are inherently paternalistic — that they use the authority and resources of the state to shape individual behavior in ways that individuals have not consented to. Engage with this critique using the alignment with audience interests criterion. Is anti-tobacco communication paternalistic? Does it matter whether it is, if the campaign is accurate, transparent, and effective?

3. The D.A.R.E. failure suggests that accuracy and proportionality are not only ethical requirements but also effectiveness requirements. Does this mean that ethical persuasion is always more effective than unethical persuasion? Or is the relationship more complex? What would you need to believe for "ethics and effectiveness are aligned" to be a reliable guide to communication design?

4. "The Real Cost" campaign's ethical success depended partly on its institutional context: FDA funding, independent evaluation, public accountability. Could a nonprofit or advocacy organization without those institutional resources achieve the same ethical standard? What would be required?

See also: Case Study 36.2 (Advocacy Journalism and Transparency); Chapter 26 (Public Health and Anti-Science); Chapter 34 (Ethics of Persuasion); Chapter 15 (Advertising and Commercial Persuasion)